0001209191-23-037192.txt : 20230614 0001209191-23-037192.hdr.sgml : 20230614 20230614190237 ACCESSION NUMBER: 0001209191-23-037192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230614 DATE AS OF CHANGE: 20230614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Karen L. CENTRAL INDEX KEY: 0001639637 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40384 FILM NUMBER: 231015604 MAIL ADDRESS: STREET 1: C/O JAZZ PHARMACEUTICALS PLC STREET 2: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD CITY: DUBLIN L2 4 STATE: L2 ZIP: 0 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Talaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001827506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 570 PRESTON ST. STREET 2: SUITE 400 CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 502-398-9250 MAIL ADDRESS: STREET 1: 93 WORCESTER STREET CITY: WELLESLEY STATE: MA ZIP: 02481 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-13 0 0001827506 Talaris Therapeutics, Inc. TALS 0001639637 Smith Karen L. C/O TALARIS THERAPEUTICS, INC. 93 WORCESTER ST. WELLESLEY MA 02481 1 0 0 0 0 Stock Option (Right to Buy) 2.54 2023-06-13 4 A 0 20500 0.00 A 2033-06-13 Common Stock 20500 20500 D The shares underlying this option shall vest as follows: the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting. /s/ Mary Kay Fenton, attorney-in-fact 2023-06-14